title: Restoration of radiation therapy-induced salivary gland dysfunction in mice by post therapy IGF-1 administration.
abstract: BACKGROUND
  Radiotherapy for head and neck cancer results in severe and chronic salivary gland dysfunction in most individuals. This results in significant side effects including xerostomia, dysphagia, and malnutrition which are linked to significant reductions in patients' quality of life. Currently there are few xerostomia treatment approaches that provide long-term results without significant side effects. To address this problem we investigated the potential for post-therapeutic IGF-1 to reverse radiation-induced salivary gland dysfunction.
  
  
  METHODS
  FVB mice were treated with targeted head and neck radiation and significant reductions in salivary function were confirmed 3 days after treatment. On days 4-8 after radiation, one group of mice was injected intravenously with IGF-1 while a second group served as a vehicle control. Stimulated salivary flow rates were evaluated on days 30, 60, and 90 and histological analysis was performed on days 9, 30, 60, and 90.
  
  
  RESULTS
  Irradiated animals receiving vehicle injections have 40-50% reductions in stimulated salivary flow rates throughout the entire time course. Mice receiving injections of IGF-1 have improved stimulated salivary flow rates 30 days after treatment. By days 60-90, IGF-1 injected mice have restored salivary flow rates to unirradiated control mice levels. Parotid tissue sections were stained for amylase as an indicator of functioning acinar cells and significant reductions in total amylase area are detected in irradiated animals compared to unirradiated groups on all days. Post-therapeutic injections of IGF-1 results in increased amylase-positive acinar cell area and improved amylase secretion. Irradiated mice receiving IGF-1 show similar proliferation indices as untreated mice suggesting a return to tissue homeostasis.
  
  
  CONCLUSIONS
  Post-therapeutic IGF-1 treatment restores salivary gland function potentially through normalization of cell proliferation and improved expression of amylase. These findings could aid in the rational design of therapy protocols or drugs for the treatment of radiation-induced salivary gland dysfunction in patients who have completed their anti-cancer therapies.
authors.affiliation: Department of Nutritional Sciences, University of Arizona, Tucson, AZ, USA.
authors.forename: Oliver
authors.initials: O
authors.lastname: Grundmann
authors.forename: Jamia L
authors.initials: JL
authors.lastname: Fillinger
authors.forename: Kerton R
authors.initials: KR
authors.lastname: Victory
authors.forename: Randy
authors.initials: R
authors.lastname: Burd
authors.forename: Kirsten H
authors.initials: KH
authors.lastname: Limesand
mesh_terms: D000818:Animals; D049109:Cell Proliferation / Q000187:drug effects / Q000528:radiation effects; D005260:Female; D005720:Gamma Rays; D006258:Head and Neck Neoplasms / Q000473:pathology / Q000532:radiotherapy*; D007334:Insulin-Like Growth Factor I / Q000008:administration & dosage*; D051379:Mice; D011379:Prognosis; D011833:Radiation Injuries, Experimental / Q000473:pathology / Q000517:prevention & control*; D012469:Salivary Glands / Q000187:drug effects* / Q000473:pathology / Q000528:radiation effects*; D014987:Xerostomia / Q000209:etiology / Q000517:prevention & control*
chemical_list: D007334:Insulin-Like Growth Factor I